167 related articles for article (PubMed ID: 28990105)
1. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
[TBL] [Abstract][Full Text] [Related]
2. miR‑15a‑5p acts as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Zhang Z; Gui Y; Mao X; Yang S; Lai Y
Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma.
Chen P; Lin C; Quan J; Lai Y; He T; Zhou L; Pan X; Wu X; Wang Y; Ni L; Yang S; Wang T; Lai Y
Mol Med Rep; 2017 Oct; 16(4):5023-5030. PubMed ID: 28765937
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR‑195‑3p as an oncogene in RCC.
Jin L; Li X; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2017 Apr; 15(4):1916-1924. PubMed ID: 28260025
[TBL] [Abstract][Full Text] [Related]
8. Identification of miR‑30b as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
10. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
[TBL] [Abstract][Full Text] [Related]
12. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
Mol Med Rep; 2018 Jun; 17(6):8510-8517. PubMed ID: 29693121
[TBL] [Abstract][Full Text] [Related]
13. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
Zhao L; Quan J; Li Z; Pan X; Wang J; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Chen Y; Lai Y
Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376
[TBL] [Abstract][Full Text] [Related]
15. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
Sun C; Sun C; Zhou Y; Yang G; Li G; Xiang C; Ding X; Sun J
Mol Med Rep; 2019 Dec; 20(6):5208-5215. PubMed ID: 31661131
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma.
Su Z; Ni L; Yu W; Yu Z; Chen D; Zhang E; Li Y; Wang Y; Li X; Yang S; Gui Y; Lai Y; Ye J
Mol Med Rep; 2015 Mar; 11(3):2248-54. PubMed ID: 25405789
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
[TBL] [Abstract][Full Text] [Related]
19. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
20. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
